Predictive factors for overall and progression-free survival, and dissemination in oligodendroglial tumors

被引:19
|
作者
Kanamori, Masayuki [1 ]
Kumabe, Toshihiro [1 ]
Sonoda, Yukihiko [1 ]
Nishino, Yoshikazu [2 ]
Watanabe, Mika [3 ]
Tominaga, Teiji [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Miyagi Canc Ctr, Res Inst, Div Epidemiol, Natori, Miyagi 9811293, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808574, Japan
关键词
Oligodendroglioma; Dissemination; Predictive factors; Nestin Ki-67; LOW-GRADE OLIGODENDROGLIOMAS; PHASE-III TRIAL; GLIOBLASTOMA-MULTIFORME; PROGNOSTIC-SIGNIFICANCE; EXPRESSION; GLIOMAS; CHEMOTHERAPY; RADIOTHERAPY; MARKERS; NESTIN;
D O I
10.1007/s11060-008-9762-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The pattern of recurrence and predictive factors for tumor progression, dissemination and survival in oligodendroglial tumors were investigated. 56 consecutive patients with oligodendroglial tumors were retrospectively analyzed to determine the predictive significance of various factors, including World Health Organization grade, loss of chromosomes 1p and 19q, and immunohistochemical features of TP53, O-6-methylguanine-deoxyribonucleic-acid-methyltransferase, CD44H, nestin, and Ki-67. Eleven patients developed dissemination, and had significantly shorter post-progression survival compared to ten patients with local recurrence. Univariate analysis showed that retention of chromosome 1p or 19q, Ki-67 labeling index a parts per thousand yen 25%, diffuse expression of nestin, and p53 labeling index a parts per thousand yen 10% were unfavorable factors for overall, progression-free, and dissemination-free survival. Multivariate analysis showed that Ki-67 labeling index a parts per thousand yen 25% and diffuse expression of nestin were significant for dissemination-free survival. In conclusion, post-progression survival shows significant differences between patients with local and disseminated recurrence. Ki-67 labeling index and nestin expression pattern are useful markers to predict dissemination.
引用
收藏
页码:219 / 228
页数:10
相关论文
共 50 条
  • [21] Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors
    Schoenfeld, David A.
    DRUGS, 2017, 77 (10) : 1137 - 1138
  • [22] Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival
    Chen, James X.
    Rose, Steven
    White, Sarah B.
    El-Haddad, Ghassan
    Fidelman, Nicholas
    Yarmohammadi, Hooman
    Hwang, Winifred
    Sze, Daniel Y.
    Kothary, Nishita
    Stashek, Kristen
    Wileyto, E. Paul
    Salem, Riad
    Metz, David C.
    Soulen, Michael C.
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2017, 40 (01) : 69 - 80
  • [23] Comment on: Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors
    David A. Schoenfeld
    Drugs, 2017, 77 : 1137 - 1138
  • [24] Correlation of progression-free and post-progression survival with overall survival in advanced colorectal cancer
    Petrelli, F.
    Barni, S.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 186 - 192
  • [25] Impact of Race on Progression-Free Survival and Overall Survival in Patients with Multiple Myeloma
    Wani, Kashmira
    Gutta, Radhika
    Mittal, Aayush
    Jamil, Maria
    Springer, Kylie
    Kuriakose, Philip
    BLOOD, 2023, 142
  • [27] RELATIONSHIP BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN CHRONIC LYMPHOCYTIC LEUKEMIA
    Beauchemin, C.
    Johnston, J.
    Lapierre, M. E.
    Aissa, F.
    Lachaine, J.
    VALUE IN HEALTH, 2012, 15 (07) : A414 - A415
  • [28] Relationship Between Progression-Free Survival and Overall Survival Benefit: A Simulation Study
    Zhang, Lijun
    Ko, Chia-Wen
    Tang, Shenghui
    Sridhara, Rajeshwari
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2013, 47 (01) : 95 - 100
  • [29] Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
    Beauchemin, Catherine
    Cooper, Dan
    Lapierre, Marie-Eve
    Yelle, Louise
    Lachaine, Jean
    ONCOTARGETS AND THERAPY, 2014, 7 : 1101 - 1110
  • [30] Relationship Between Progression-Free Survival and Overall Survival Benefit: A Simulation Study
    Lijun Zhang
    Chia-Wen Ko
    Shenghui Tang
    Rajeshwari Sridhara
    Therapeutic Innovation & Regulatory Science, 2013, 47 : 95 - 100